19.6 C
New York
Saturday, June 3, 2023

Investing In Heron Therapeutics Inc. (NASDAQ: HRTX): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Heron Therapeutics Inc. (HRTX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0192, or 1.54%, to $1.2692. The Heron Therapeutics Inc. has recorded 12,300 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2023 and Highlights Recent Corporate Updates.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $1.25 and fluctuated between $1.3100 as its day high and $1.1600 as its day low. The current market capitalization of Heron Therapeutics Inc. is $138.18M. A total of 2.43 million shares were traded on the day, compared to an average of 2.48M shares.

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, HRTX has seen 8 BUY and 4 SELL insider trades, representing the acquisition of 19,926 and the disposition of 6,301 shares. Over the last 12 months, there were 46 BUYs and 19 SELLs from insiders. Insiders purchased 336,874 shares during that period but sold 42,800.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for HRTX in the last 3 months, the mean price target is $7.92 with high estimates of $10.00 and low estimates of $5.50. In terms of 52-week highs and lows, HRTX has a high of $5.62 and a low of $1.07.

As of this writing, HRTX has an earnings estimate of -$0.23 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.26. The company reported an EPS of -$0.17 in the last quarter, which was 39.30% higher than expectations of -$0.28.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HRTX’s latest balance sheet shows that the firm has $157.58M in Cash & Short Term Investments as of fiscal 2021. There were $159.50M in debt and $71.06M in liabilities at the time. Its Book Value Per Share was -$0.10, while its Total Shareholder’s Equity was $77.57M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HRTX is Buy with a score of 4.80.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles